These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 11567957)

  • 1. The effect on intraocular pressure of latanoprost once or four times daily.
    Lindén C; Alm A
    Br J Ophthalmol; 2001 Oct; 85(10):1163-6. PubMed ID: 11567957
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effect of non-steroidal anti-inflammatory ophthalmic solution on intraocular pressure reduction by latanoprost.
    Kashiwagi K; Tsukahara S
    Br J Ophthalmol; 2003 Mar; 87(3):297-301. PubMed ID: 12598441
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Intraocular pressure-reducing effects and safety of latanoprost versus timolol in patients with chronic angle-closure glaucoma.
    Chew PT; Aung T; Aquino MV; Rojanapongpun P;
    Ophthalmology; 2004 Mar; 111(3):427-34. PubMed ID: 15019314
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of two- and three-times-daily topical ophthalmic application of 0.005% latanoprost solution in clinically normal dogs.
    Tofflemire KL; Whitley EM; Allbaugh RA; Ben-Shlomo G; Robinson CC; Overton TL; Thiessen CE; Evans EA; Griggs AN; Adelman SA; Ludwig AL; Jens JK; Ellinwood NM; Peterson CS; Whitley RD
    Am J Vet Res; 2015 Jul; 76(7):625-31. PubMed ID: 26111092
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of 0.005% latanoprost solution on intraocular pressure in healthy dogs and cats.
    Studer ME; Martin CL; Stiles J
    Am J Vet Res; 2000 Oct; 61(10):1220-4. PubMed ID: 11039551
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Latanoprost twice daily is less effective than once daily: indication of receptor subsensitivity?
    Lindén C; Alm A
    Curr Eye Res; 1998 Jun; 17(6):567-72. PubMed ID: 9663846
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Intraocular pressure lowering effect of once daily versus once weekly latanoprost instillation in the same normal individuals.
    Darhad U; Nakamura M; Fujioka M; Tatsumi Y; Nagai-Kusuhara A; Maeda H; Negi A
    Kobe J Med Sci; 2008 Feb; 53(6):297-304. PubMed ID: 18762724
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects on intraocular pressure and aqueous flow of various dose regimens of latanoprost in human eyes.
    Lindén C; Alm A
    Acta Ophthalmol Scand; 1997 Aug; 75(4):412-5. PubMed ID: 9374251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A 6-week, multicenter, randomized, double-masked, parallel-group study comparing travoprost 0.004% to latanoprost 0.005% followed by 6-week, open-label treatment with travoprost 0.004%.
    Maul E; Carrasco FG; Costa VP; Casiraghi JF; Vargas E; Sarmina JS; Mayol R
    Clin Ther; 2007 Sep; 29(9):1915-23. PubMed ID: 18035191
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of topical latanoprost on optic nerve head circulation in rabbits, monkeys, and humans.
    Ishii K; Tomidokoro A; Nagahara M; Tamaki Y; Kanno M; Fukaya Y; Araie M
    Invest Ophthalmol Vis Sci; 2001 Nov; 42(12):2957-63. PubMed ID: 11687542
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A randomised, controlled comparison of latanoprostene bunod and latanoprost 0.005% in the treatment of ocular hypertension and open angle glaucoma: the VOYAGER study.
    Weinreb RN; Ong T; Scassellati Sforzolini B; Vittitow JL; Singh K; Kaufman PL;
    Br J Ophthalmol; 2015 Jun; 99(6):738-45. PubMed ID: 25488946
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Intraocular pressure over 24 hours after single-dose administration of latanoprost 0.005% in healthy volunteers. A randomized, double-masked, placebo controlled, cross-over single center study.
    Larsson LI
    Acta Ophthalmol Scand; 2001 Dec; 79(6):567-71. PubMed ID: 11782220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Switching from latanoprost to fixed-combination latanoprost-timolol: a 21-day, randomized, double-masked, active-control study in patients with glaucoma and ocular hypertension.
    Olander K; Zimmerman TJ; Downes N; Schoenfelder J;
    Clin Ther; 2004 Oct; 26(10):1619-29. PubMed ID: 15598478
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A double masked comparison of the intraocular pressure reducing effect of latanoprost 0.005% and 0.001% administered once daily in open angle glaucoma and ocular hypertension.
    Friström B; Nilsson SE
    Br J Ophthalmol; 1997 Oct; 81(10):867-70. PubMed ID: 9486028
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of topical ophthalmic latanoprost 0.005% solution alone and in combination with diclofenac 0.1% solution in healthy horses: a pilot study.
    Tofflemire K; Whitley EM; Allbaugh R; Ben-Shlomo G; Griggs A; Strong T; Whitley RD
    Vet Ophthalmol; 2017 Sep; 20(5):398-404. PubMed ID: 27791324
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Additive effect of unoprostone and latanoprost in patients with elevated intraocular pressure.
    Aung T; Chew PT; Oen FT; Chan YH; Thean LH; Yip L; Lim BA; Soh J; Seah SK
    Br J Ophthalmol; 2002 Jan; 86(1):75-9. PubMed ID: 11801508
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prostaglandin analogues and mouse intraocular pressure: effects of tafluprost, latanoprost, travoprost, and unoprostone, considering 24-hour variation.
    Ota T; Murata H; Sugimoto E; Aihara M; Araie M
    Invest Ophthalmol Vis Sci; 2005 Jun; 46(6):2006-11. PubMed ID: 15914616
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Using diurnal intraocular pressure fluctuation to assess the efficacy of fixed-combination latanoprost/timolol versus latanoprost or timolol monotherapy.
    Varma R; Hwang LJ; Grunden JW; Bean GW
    Br J Ophthalmol; 2010 Jan; 94(1):80-4. PubMed ID: 19692375
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A phase 2, randomized, dose-response trial of taprenepag isopropyl (PF-04217329) versus latanoprost 0.005% in open-angle glaucoma and ocular hypertension.
    Schachar RA; Raber S; Courtney R; Zhang M
    Curr Eye Res; 2011 Sep; 36(9):809-17. PubMed ID: 21851167
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Reduction of intraocular pressure in mouse eyes treated with latanoprost.
    Aihara M; Lindsey JD; Weinreb RN
    Invest Ophthalmol Vis Sci; 2002 Jan; 43(1):146-50. PubMed ID: 11773025
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.